HASHEM EL-SERAG to Liver
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Liver.
Connection Strength
0.316
-
How we approach it: treatment options for hepatocellular carcinoma. Am J Gastroenterol. 2018 06; 113(6):791-794.
Score: 0.090
-
Hepatocellular carcinoma. N Engl J Med. 2011 Sep 22; 365(12):1118-27.
Score: 0.057
-
Statin therapy and serum transaminases among a cohort of HCV-infected veterans. Dig Dis Sci. 2010 Jan; 55(1):190-5.
Score: 0.050
-
Management of the single liver nodule in a cirrhotic patient: a decision analysis model. J Clin Gastroenterol. 2005 Feb; 39(2):152-9.
Score: 0.036
-
AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19. Gastroenterology. 2020 Jul; 159(1):320-334.e27.
Score: 0.026
-
Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021 01; 19(1):61-71.e15.
Score: 0.026
-
Carbamazepine-associated severe bile duct injury. Am J Gastroenterol. 1999 Feb; 94(2):526-7.
Score: 0.024
-
Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med. 2003 Apr 15; 138(8):627-33.
Score: 0.008